Literature DB >> 26605761

Ovarian cancer: beyond resistance.

David Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26605761     DOI： 10.1038/527S217a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  46 in total

Review 1.  Expression and function of FRA1 protein in tumors.

Authors:  Xiaoyan Jiang; Hui Xie; Yingyu Dou; Jing Yuan; Da Zeng; Songshu Xiao
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.

Authors:  Bahareh Kashani; Zahra Zandi; Mohammad Reza Karimzadeh; Davood Bashash; Ali Nasrollahzadeh; Seyed H Ghaffari
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

3.  Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4.

Authors:  Jie Xi; Jing Feng; Saitian Zeng
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.

Authors:  Kalpana Deepa Priya Dorayappan; Ross Wanner; John J Wallbillich; Uksha Saini; Roman Zingarelli; Adrian A Suarez; David E Cohn; Karuppaiyah Selvendiran
Journal:  Oncogene       Date:  2018-04-11       Impact factor: 9.867

5.  Cisplatin-mediated down-regulation of miR-145 contributes to up-regulation of PD-L1 via the c-Myc transcription factor in cisplatin-resistant ovarian carcinoma cells.

Authors:  Q Sheng; Y Zhang; Z Wang; J Ding; Y Song; W Zhao
Journal:  Clin Exp Immunol       Date:  2019-12-27       Impact factor: 4.330

6.  [High expression of STAT2 in ovarian cancer and its effect on metastasis of ovarian cancer cells].

Authors:  Xuan Chen; Jingying Huang; Yuchun Lü
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

7.  Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.

Authors:  Irma Virant-Klun; Martin Stimpfel
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

8.  Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity.

Authors:  Bangxing Hong; Valerie Chapa; Uksha Saini; Puneet Modgil; David E Cohn; Guangan He; Zahid H Siddik; Anil K Sood; Yuanqing Yan; Karuppaiyah Selvendiran; Guangsheng Pei; Zhongming Zhao; Ji Young Yoo; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2020-10-21       Impact factor: 12.531

9.  Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.

Authors:  Elina A Pietilä; Jordi Gonzalez-Molina; Lidia Moyano-Galceran; Sanaz Jamalzadeh; Kaiyang Zhang; Laura Lehtinen; S Pauliina Turunen; Tomás A Martins; Okan Gultekin; Tarja Lamminen; Katja Kaipio; Ulrika Joneborg; Johanna Hynninen; Sakari Hietanen; Seija Grénman; Rainer Lehtonen; Sampsa Hautaniemi; Olli Carpén; Joseph W Carlson; Kaisa Lehti
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

10.  Differential network analysis from cross-platform gene expression data.

Authors:  Xiao-Fei Zhang; Le Ou-Yang; Xing-Ming Zhao; Hong Yan
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.